Vantage Point

November 2012
Medical Marketing & Media;Nov2012, Vol. 47 Issue 11, p30
Trade Publication
The article reports on the efforts of drug manufacturers in the U.S. to develop effective marketing strategies in 2012.


Related Articles

  • Taking Advantage of the Science Behind Marketing. Chapin, David // Pharmaceutical Representative;Jan2011, Vol. 41 Issue 1, p28 

    The article focuses on marketing strategies in the pharmaceutical industry in the U.S. It notes the experiment which aims to determine the industry' immunity to marketing influences. The author also discusses the relationship between the marketer and the purchaser as well as the general...

  • Where have all the Scientists Gone?  // Pharmaceutical Executive;Mar2011, Vol. 31 Issue 3, p16 

    The article presents the view of the author on the Mechanism of Action (MOA) concept of marketing in the pharmaceutical industry in the U.S. According to the author, the MOA can be generated to support scientific approach in pharmaceutical marketing. The author also mentions that the MOA can...

  • Angrier Birds. Chapman, David // Pharmaceutical Executive;Jun2011, Vol. 31 Issue 6, p104 

    The author discusses the need for pharmaceutical companies to develop strategies that will protect their innovator brands in the U.S. He advises companies to conduct research to gather patients and health care providers' data to determine the right target of their product. The author asserts the...

  • Growing pains, growing sales. Comer, Ben // Medical Marketing & Media;Jan2011, Vol. 46 Issue 1, p42 

    The article profiles pharmaceutical company Purdue Pharma LP, which was awarded as the periodical's Small Pharmaceutical Marketing Team of the Year 2011 for its OxyContin pill in the U.S. The firm has launched a website designed to promote Risk Management and Mitigation Strategy (REMS) program...

  • Branding a Unique Story. Colucci, Nick // Pharmaceutical Executive;Jun2011, Vol. 31 Issue 6, p94 

    The author discusses the importance for pharmaceutical companies to create a marketing strategy for their first-in-class brands in the U.S. He cites the need for pharmaceutical companies to create an awareness program about the growing or little-recognize disease for the people to acknowledge...

  • The futuristic insight. Gratton, Fabio; Mannion, Martin // Pharmaceutical Executive;Jun2011, Vol. 31 Issue 6, p112 

    The author discusses the importance for marketers in the pharmaceutical industry to create and manage expectations as the most basic rule in their marketing approach in the U.S. He cites the need for companies to leverage interest among healthcare professionals and consumers about their product....

  • Digital's Place in the Pharma Marketing Mix. Perlotto, Mark // Pharmaceutical Executive;Nov2014, Vol. 34 Issue 11, p40 

    The article presents the author's views on the use of digital media in marketing drugs in the U.S. He comments that digital tools could help marketers to achieve extraordinary things. He opines that basics of marketing need to be considered while determining the proper place of digital media in...

  • Promotion optimization lures shoppers. Kantor, Mike // Drug Store News;3/14/2011, Vol. 33 Issue 4, p14 

    In this article, the author discusses aspects of the promotion optimization for healthcare products in the U.S. He discusses the impact of promotion optimization not only for consumers but also for retailers and manufacturers. He emphasizes that stores that optimize promotions differentiate and...

  • Game Is Changing for Rx Makers.  // Chain Drug Review;8/29/2011, Vol. 33 Issue 14, p89 

    The article reports on the need for drug companies to find new ways to innovate and adapt to rapid market changes in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics